Acquired Organization:
- Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Acquiring Organization:
- Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Announced Date Nov 8, 2010 Acquisition Type Acquisition Price $800M Acquisition Status Complete Disposition of Acquired Organization Subsidiary Acquisition Terms Cash & Stock